ESSA Pharma Inc.

NASDAQ: EPIX · Real-Time Price · USD
1.93
0.01 (0.52%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.00%
After-hours: Aug 15, 2025, 07:33 PM EDT

ESSA Pharma Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Cash & Equivalents
103.71M 33.7M 57.08M 137.83M
Short-Term Investments
23.05M 114.37M 110.16M 57.1M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
256.98K 257.25K 259.45K 259.45K
Receivables
162.97K 135.06K 6.21K 489.01K
Inventory
n/a n/a 110.61M n/a
Other Current Assets
n/a 378.75K n/a n/a
Total Current Assets
127.56M 148.8M 169.5M 197.6M
Property-Plant & Equipment
295.47K 68.01K 186.5K 308.29K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
552.45K 325.25K 445.95K 567.74K
Total Assets
128.11M 149.12M 169.5M 198.17M
Account Payables
2.4M 2.03M 954.6K 1.43M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
601.76K 540.75K n/a n/a
Total Current Liabilities
3.3M 3.5M 2.31M 3.93M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 183.00 20.35K
Total Long-Term Liabilities
205.21K n/a 77K 230.6K
Total Liabilities
3.51M 3.5M 2.39M 4.16M
Total Debt
329.26K 80.33K 209.83K 330.97K
Common Stock
n/a 278.16M 278.09M 277.42M
Retained Earnings
n/a -179.46M -152.88M -117.78M
Comprehensive Income
-2.06M -2.12M -2.14M -2.08M
Shareholders Equity
128.11M 145.63M 167.12M 194.01M
Total Investments
23.05M 114.37M 110.16M 57.1M